Alexza Pharmaceuticals
3.3 of 5 7 reviews
Mountain View, CA
50 to 149 Employees
Company - Public (ALXA)
Biotech & Pharmaceuticals
$25 to $50 million (USD) per year

Alexza Pharmaceuticals is focused on the development and manufacture of novel proprietary products for acute treatment of underserved medical needs. Our commercial product and pipeline candidates are... More

Mission: Strategically, we are focused on finding new therapeutic...More

Alexza Pharmaceuticals – Why Work For Us? Provided by employer [?]

  • About Us  | 
  • Careers at Alexza  | 
  • Benefits  | 
  • Community Relations


Alexza Pharmaceuticals is a rapidly emerging pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS conditions. All of our product candidates are based on our proprietary technology, the Staccato® system. The Staccato system vaporizes excipient-free drugs to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. Because of the ideal particle size of the aerosol, the pure drug is quickly absorbed through the deep lung into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous (IV) administration but with greater ease, patient comfort and convenience.


Alexza's lead program is ADASUVE™ (Staccato loxapine or AZ-004), being developed for the acute treatment of agitation in patients with schizophrenia or bipolar disease, and has regulatory processes ongoing in both the United States and Europe.

Recent Highlights:

  • In October 2011, Alexza entered into a commercial partnership for ADASUVE™ with Grupo Ferrer Internacional, S.A. for the commercialization of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.
  • In October 2011, Alexza filed its Marketing Authorization Application (MAA) for ADASUVE with the European Medicines Agency (EMA).
  • In May 2012, Alexza received a Complete Response Letter (CRL) from the FDA regarding our ADASUVE NDA in which manufacturing deficiencies were noted by the FDA. There were no new clinical or safety issues identified, and there were no other deficiencies outlined.
  • In June 2012, Alexza resubmitted the ADASUVE NDA seeking marketing approval for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. In July 2012, the FDA accepted the resubmission as a complete class 2 response and indicated a Prescription Drug User Fee Act (PDUFA) goal date of December 21, 2012.

To summarize, our efforts in early 2012 were highly focused on what we felt were the key drivers of stockholder value, the continued hard work on moving ADASUVE forward in its regulatory processes.

We believe we are pioneering a genuinely revolutionary technology that can greatly improve the treatment of many patients suffering with acute and intermittent conditions, and in some cases, fundamentally change the way that medicine is practiced. Our overriding goals are to bring the company's first product, ADASUVE, through the NDA and MAA review and approval processes, while at the same time, finding ways to continue to develop our other product candidates.


Working at Alexza Pharmaceuticals

Posted by employees

Employees say it's “OK”   7 ratings


71% Approve of the CEO   7 ratings

Alexza Pharmaceuticals President, CEO, and Director Thomas B. King

Thomas B. King

President, CEO, and Director

Alexza Activities & Community Relations Committee does a great job

 Current Employee in Mountain View, CA

Pros: The team of over a dozen Alexza employee volunteers from various groups within Alexza have 1-2 activities every month including community relations functions. Full Review

More Alexza Pharmaceuticals Ratings & Reviews ( 7)

Salaries in USD  United States Avg. Salary

Validation Engineer IV

2 Alexza Pharmaceuticals Salaries


Stability Coordinator

1 Alexza Pharmaceuticals Salary


Engineer III

1 Alexza Pharmaceuticals Salary


= Salary Range

= Anonymous Salary Range

= Avg.

More Alexza Pharmaceuticals Salaries (7)

Accepted Offer – Reviewed Jan 30, 2014

Interview Details – My total interview time last about 6-7 hours over one phone interview and two separate days. I talked to 8 different people total, almost half of them in senior management. That was probably the most intimidating part, interviewing with directors, VPs, and Sr. VPs, but surprisingly, it was pretty…Full Interview

Interview Question:
The most difficult part of the interview was probably the initial phone interview. She asked me very detailed and specific questions about every aspect of the job I was applying for. In addition, I… Answer Question

More Alexza Pharmaceuticals Interview Questions & Reviews (2)

Alexza Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Worked for Alexza Pharmaceuticals? Contribute to the Community!

Financial Information

Glassdoor is your free inside look at what it's like to work at Alexza Pharmaceuticals - including salaries, reviews, office photos, and more. All content posted anonymously by employees working at Alexza Pharmaceuticals.